Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Rimner

Showing results (121-130 of 272) with videos related to

Pageof 28
Sort By:
Physics and Imaging in Radiation Oncology|May 16, 2020
Quantification of accumulated dose and associated anatomical changes of esophagus using weekly Magnetic Resonance Imaging acquired during radiotherapy of locally advanced lung cancerSadegh Alam, Maria Thor, Andreas Rimner, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 2014
Erlotinib versus radiation therapy for brain metastases in patients with EGFR-mutant lung adenocarcinomaNaamit K Gerber, Yoshiya Yamada, Andreas Rimner, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 14, 2014
Outcome of primary neuroendocrine tumors of the thymus: a joint analysis of the International Thymic Malignancy Interest Group and the European Society of Thoracic Surgeons databasesPier Luigi Filosso, Xiaopan Yao, Usman Ahmad, et al.
Annals of Surgical Oncology|December 25, 2012
Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgeryArya Amini, Feiran Lou, Arlene M Correa, et al.
Advances in Radiation Oncology|December 6, 2017
Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancerBenjamin H Lok, Jennifer Ma, Amanda Foster, et al.
Medical Physics|February 20, 2018
Radiomics analysis of pulmonary nodules in low-dose CT for early detection of lung cancerWookjin Choi, Jung Hun Oh, Sadegh Riyahi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2013
Stereotactic body radiation therapy for primary lung cancers >3 centimetersJohn J Cuaron, Ellen D Yorke, Amanda Foster, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 2016
Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation TherapyJonathan E Leeman, Andreas Rimner, Joseph Montecalvo, et al.
Lung Cancer (Amsterdam, Netherlands)|June 17, 2015
FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancerZachary A Kohutek, Abraham J Wu, Zhigang Zhang, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 20, 2014
Thymic carcinoma outcomes and prognosis: results of an international analysisUsman Ahmad, Xiaopan Yao, Frank Detterbeck, et al.
Pageof 28

Showing results (121-130 of 272) with videos related to

Sort By:
Pageof 28
Physics and Imaging in Radiation Oncology|May 16, 2020
Quantification of accumulated dose and associated anatomical changes of esophagus using weekly Magnetic Resonance Imaging acquired during radiotherapy of locally advanced lung cancerSadegh Alam, Maria Thor, Andreas Rimner, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 2014
Erlotinib versus radiation therapy for brain metastases in patients with EGFR-mutant lung adenocarcinomaNaamit K Gerber, Yoshiya Yamada, Andreas Rimner, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 14, 2014
Outcome of primary neuroendocrine tumors of the thymus: a joint analysis of the International Thymic Malignancy Interest Group and the European Society of Thoracic Surgeons databasesPier Luigi Filosso, Xiaopan Yao, Usman Ahmad, et al.
Annals of Surgical Oncology|December 25, 2012
Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgeryArya Amini, Feiran Lou, Arlene M Correa, et al.
Advances in Radiation Oncology|December 6, 2017
Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancerBenjamin H Lok, Jennifer Ma, Amanda Foster, et al.
Medical Physics|February 20, 2018
Radiomics analysis of pulmonary nodules in low-dose CT for early detection of lung cancerWookjin Choi, Jung Hun Oh, Sadegh Riyahi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2013
Stereotactic body radiation therapy for primary lung cancers >3 centimetersJohn J Cuaron, Ellen D Yorke, Amanda Foster, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 2016
Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation TherapyJonathan E Leeman, Andreas Rimner, Joseph Montecalvo, et al.
Lung Cancer (Amsterdam, Netherlands)|June 17, 2015
FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancerZachary A Kohutek, Abraham J Wu, Zhigang Zhang, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 20, 2014
Thymic carcinoma outcomes and prognosis: results of an international analysisUsman Ahmad, Xiaopan Yao, Frank Detterbeck, et al.
Pageof 28